(Q70469480)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394365%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

title

Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394365%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

author name string

B A Teicher

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394365%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

S A Holden

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394365%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

V Khandakar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394365%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

T S Herman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394365%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394365%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

11 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394365%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394365%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394365%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

page(s)

645-651

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394365%20AND%20SRC:MED&resulttype=core&format=json

Recent studies of DNA topoisomerases

11 October 2019

cites work

1 reference

12 December 2020

Synergistic cell killing by ionizing radiation and topoisomerase I inhibitor topotecan (SK&F 104864)

1 reference

12 December 2020

Reduced DNA break formation and cytotoxicity of the topoisomerase II drug 4'-(9'-acridinylamino)methanesulfon-m-anisidide when combined with hyperthermia in human and rodent cell lines

1 reference

12 December 2020

Trimodality therapy (drug/hyperthermia/radiation) with BCNU or mitomycin C.

1 reference

12 December 2020

Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity

1 reference

12 December 2020

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor

1 reference

12 December 2020

Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts

1 reference

12 December 2020

Ability of four potential topoisomerase II inhibitors to enhance the cytotoxicity of cis-diamminedichloroplatinum (II) in Chinese hamster ovary cells and in an epipodophyllotoxin-resistant subline

1 reference

12 December 2020

DNA topoisomerase poisons as antitumor drugs

1 reference

12 December 2020

Irreversible trapping of the DNA-topoisomerase I covalent complex. Affinity labeling of the camptothecin binding site

1 reference

12 December 2020

Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies

1 reference

12 December 2020

Influence of growth state on several thermal responses of EMT6/Az tumor cells in vitro

1 reference

12 December 2020

Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cells

1 reference

12 December 2020

Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative.

1 reference

12 December 2020

The interaction of cisplatin plus etoposide with radiation +/- hyperthermia

1 reference

12 December 2020

Sequencing of trimodality therapy [cis-diamminedichloroplatinum(II)/hyperthermia/radiation] as determined by tumor growth delay and tumor cell survival in the FSaIIC fibrosarcoma

1 reference

12 December 2020

Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.

1 reference

12 December 2020

DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts

1 reference

12 December 2020

Effects of CPT-11 in combination with other anti-cancer agents in culture

1 reference

12 December 2020

Effect of temperature on the cytotoxicity of vindesine, amsacrine, and mitoxantrone

1 reference

12 December 2020

Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model

1 reference

12 December 2020

Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells

1 reference

12 December 2020

Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues withcis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation

1 reference

12 December 2020

Combination of etanidazole with cyclophosphamide and platinum complexes

1 reference

12 December 2020

Modulation of alkylating agents by lonidamine in vivo

1 reference

12 December 2020

Effect of hypoxia and acidosis on the cytotoxicity of mitoxantrone, bisantrene and amsacrine and their platinum complexes at normal and hyperthermic temperatures

1 reference

12 December 2020

Perfluorochemical emulsions can increase tumor radiosensitivity

1 reference

12 December 2020

Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin

1 reference

12 December 2020

Lonidamine as a modulator of alkylating agent activity in vitro and in vivo

1 reference

12 December 2020

Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin

1 reference

12 December 2020

Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo

1 reference

12 December 2020

Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells

1 reference

12 December 2020

Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin.

1 reference

12 December 2020

Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma

1 reference

12 December 2020

Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells

1 reference

12 December 2020

Interaction of D,L- and D-tetraplatin with hyperthermia in vitro and in vivo

1 reference

12 December 2020

Modification of Cell Lethality at Elevated Temperatures The pH Effect

1 reference

12 December 2020

Combination chemotherapy in vitro with cis-dichlorodiammineplatinum(II)

1 reference

12 December 2020

Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.

1 reference

12 December 2020

Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma

1 reference

12 December 2020

Blood flow, oxygen consumption, and tissue oxygenation of human breast cancer xenografts in nude rats

1 reference

12 December 2020

Radiosensitization of EMT6 cells by four platinum complexes.

1 reference

12 December 2020

Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro

1 reference

12 December 2020

Effects of camptothecin on the breakage and repair of DNA during the cell cycle

1 reference

12 December 2020

In vivo-in vitro tumor systems: new models for studing the response of tumours to therapy

1 reference

12 December 2020

Thermal analysis of CHL V79 cells using differential scanning calorimetry: implications for hyperthermic cell killing and the heat shock response.

1 reference

12 December 2020

Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents

1 reference

12 December 2020

Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo

1 reference

12 December 2020

Addition of mitomycin C to cis-diamminedichloroplatinum(II)/hyperthermia/radiation therapy in the FSaIIC fibrosarcoma

1 reference

12 December 2020

Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs.

1 reference

12 December 2020

Comparison of effects of fostriecin, novobiocin, and camptothecin, inhibitors of DNA topoisomerases, on DNA replication and repair in human cells

1 reference

12 December 2020

Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro

1 reference

12 December 2020

Cellular Radiosensitivity and Tumor Radiation Response in the EMT6 Tumor Cell System

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01215982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8394365%20AND%20SRC:MED&resulttype=core&format=json

11 October 2019

1 reference